ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.96
0.71%
US Tech 100
20,762.73
1.73%
S&P 500
5,942.47
1.26%
US Dollar vs CAD
1.44457
0.00%
Bitcoin
98,277.52
0.17%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Egide Sa (0OJ4) Share Price

Egide Sa

Egide Sa (0OJ4)

LSE
2.27
0.00
(0.00%)
Closed January 04 10:30AM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
2.27
Bid
0.00
Ask
0.00
Volume
0.00
0.00 Day's Range 0.00
2.27 52 Week Range 2.27
Market Cap
36.908M
Previous Close
2.27
Open
-
Last Trade
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
147
Shares Outstanding
16,259,000
Dividend Yield
-
PE Ratio
-11.83
Earnings Per Share (EPS)
-0.19
Revenue
37.13M
Net Profit
-3.12M

About Egide Sa

Sector
Electronic Components, Nec
Industry
Electronic Components, Nec
Website
www.egide-group.com
Headquarters
Carpentras, Vaucluse, Fra
Founded
-
Egide Sa is listed in the Electronic Components sector of the London Stock Exchange with ticker 0OJ4. The last closing price for Egide was 2.27 €. Over the last year, Egide shares have traded in a share price range of 2.27 € to 2.27 €.

Egide currently has 16,259,000 shares outstanding. The market capitalization of Egide is 36.91 € million. Egide has a price to earnings ratio (PE ratio) of -11.83.

Ask ADVFN Intelligence (AI)

0OJ4 Latest News

More News

Egide: EGIDE SA STRENGTHENS ITS STRATEGIC PARTNERSHIP WITH LYNRED BY SIGNING A NEW MULTI-YEAR MASTER AGREEMENT

Egide: EGIDE SA STRENGTHENS ITS STRATEGIC PARTNERSHIP WITH LYNRED BY SIGNING A NEW MULTI-YEAR MASTER AGREEMENT Bollène (France), December 12, 2024– 06 :00pm (CET) Press Release EGIDE SA...

December 12 2024
UK Regulatory

EGIDE : EGIDE SA RENFORCE SON PARTENARIAT STRATEGIQUE AVEC LYNRED EN SIGNANT UN NOUVEAU CONTRAT CADRE PLURIANNUEL

EGIDE : EGIDE SA RENFORCE SON PARTENARIAT STRATEGIQUE AVEC LYNRED EN SIGNANT UN NOUVEAU CONTRAT CADRE PLURIANNUEL Bollène, le 12 décembre 2024– 18:00 (CET) Communiqué de presse EGIDE SA...

December 12 2024
UK Regulatory

EGIDE : EXOSENS ET EGIDE RENFORCENT LEUR PARTENARIAT HISTORIQUE

EGIDE : EXOSENS ET EGIDE RENFORCENT LEUR PARTENARIAT HISTORIQUE Bollène, 27 novembre 2024– 18:00 (CET) Communiqué de presse EXOSENS ET EGIDE RENFORCENT LEUR PARTENARIAT HISTORIQUE Egide...

November 27 2024
UK Regulatory

Egide: EXOSENS AND EGIDE STRENGTHEN THEIR LONG-STANDING PARTNERSHIP

Egide: EXOSENS AND EGIDE STRENGTHEN THEIR LONG-STANDING PARTNERSHIP Bollène (France), November 27th, 2024– 6 :00pm (CET) Press Release EXOSENS AND EGIDE STRENGTHEN THEIR LONG-STANDING...

November 27 2024
UK Regulatory

EGIDE : résultats de l'augmentation de capital

EGIDE : résultats de l'augmentation de capital Communiqué de presse Bollène, 11 novembre 2024– 8h00 (CET) Résultats de l’augmentation de capital avec maintien du DPS des actionnaires par...

November 11 2024
UK Regulatory

Egide: results of the capital increase

Egide: results of the capital increase Press Release Bollène (France), November 11, 2024– 8 :00am (CET) Results of the capital increase with preemptive subscriptionrights for shareholders by...

November 11 2024
UK Regulatory

EGIDE : Modalités de mise à disposition du rapport financier semestriel 2024

EGIDE : Modalités de mise à disposition du rapport financier semestriel 2024 Bollène, le 23 octobre 2024 – 10 :30 (CET)Communiqué de presse EGIDE annonce la mise à disposition de son rapport...

October 23 2024
UK Regulatory

Egide: results for the 1st half of 2024 - Philippe BENSUSSAN appointed Chairman - New Capital Increase

Egide: results for the 1st half of 2024 - Philippe BENSUSSAN appointed Chairman - New Capital Increase Press Release Bollène, October 22, 2024– 08:00am (CET) RESULTS FOR THE 1ST HALF OF 2024...

October 22 2024
UK Regulatory

EGIDE : Résultats S1 2024 - Philippe BENSUSSAN nommé Président - Lancement d'une augmentation de Capital

EGIDE : Résultats S1 2024 - Philippe BENSUSSAN nommé Président - Lancement d'une augmentation de Capital Communiqué de presse Bollène, 22 octobre 2024– 08:00 (CET) Résultats du 1er semestre...

October 22 2024
UK Regulatory

Egide: Philippe Bensussan Co-opted as member of Egide’s Group Board of Directors

Egide: Philippe Bensussan Co-opted as member of Egide’s Group Board of Directors Bollène (France), October 3, 2024 – 08 :00 am (CET)Press Release Philippe Bensussan Co-opted as member of Egide’s...

October 03 2024
UK Regulatory
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1002.272.272.2700DE
4002.272.272.274512.27DE
12002.272.272.271472.27DE
26002.272.272.27652.27DE
52002.272.272.27822.27DE
156002.272.272.27482.27DE
260002.272.272.27292.27DE

0OJ4 - Frequently Asked Questions (FAQ)

What is the current Egide share price?
The current share price of Egide is 2.27 €
How many Egide shares are in issue?
Egide has 16,259,000 shares in issue
What is the market cap of Egide?
The market capitalisation of Egide is EUR 36.91M
What is the 1 year trading range for Egide share price?
Egide has traded in the range of 2.27 € to 2.27 € during the past year
What is the PE ratio of Egide?
The price to earnings ratio of Egide is -11.83
What is the cash to sales ratio of Egide?
The cash to sales ratio of Egide is 0.99
What is the reporting currency for Egide?
Egide reports financial results in EUR
What is the latest annual turnover for Egide?
The latest annual turnover of Egide is EUR 37.13M
What is the latest annual profit for Egide?
The latest annual profit of Egide is EUR -3.12M
What is the registered address of Egide?
The registered address for Egide is SITE DU SACTAR, 84500 BOLLENE, CARPENTRAS, VAUCLUSE, 84500
What is the Egide website address?
The website address for Egide is www.egide-group.com
Which industry sector does Egide operate in?
Egide operates in the ELECTRONIC COMPONENTS, NEC sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TCFTheracryf Plc
0.725p
(38.10%)
7.56M
NMTNeometals Ltd
3.50p
(27.27%)
346.81k
SCHOScholium Group Plc
44.00p
(25.71%)
30.65k
FABFusion Antibodies Plc
10.15p
(24.54%)
3.34M
PYXPyx Resources Limited
3.49p
(22.24%)
8.43k
TM1Technology Minerals Plc
0.125p
(-24.24%)
37.21M
QUIZQuiz Plc
0.70p
(-18.60%)
3.67M
SYMESupply@me Capital Plc
0.003p
(-17.81%)
168.35M
OBDOxford Biodynamics Plc
1.20p
(-14.29%)
827.83k
ZENZenith Energy Ltd.
5.25p
(-13.93%)
5.39M
TRPTower Resources Plc
0.0395p
(5.33%)
539.51M
CPXCap-xx Limited
0.1825p
(1.39%)
494M
NTVONativo Resources Plc
0.0019p
(0.00%)
320.16M
DGIDg Innovate Plc
0.0225p
(-13.46%)
208.21M
ENETEthernity Networks Ltd
0.1125p
(2.27%)
207.56M

Discussion

View Full Feed
trainer2 trainer2 4 minutes ago
It's a given!
TSLA
penguin007 penguin007 5 minutes ago
That was strange...! Who was that? Why would anyone post an opinion re; buying or selling a stock with having limited information that was outdated years ago? My recommendation would, know what you own...or go home.
ZHUD
facts_matter14 facts_matter14 5 minutes ago
Please post pics! Ask Maxine why he hasn’t provided bag holders with POSVOS sales numbers and more importantly, what happened to I.Va.

Let’s not forget that E-Bike Beta Testing was supposed to begin in Q4, but we got no indication that happened.

Then again, you might no
SRMX
Huggy Bear Huggy Bear 5 minutes ago
Right. It's another highly promoted fairy tale.
HMBL
RichieBoy RichieBoy 5 minutes ago
500+ partners Golf, clearly Digibriks will create far more news moving forward. It's not all doom and gloom, it's just January. Seasonally harrumph, but there's going to be time needed to optimize the synergies of the two companies. That might take 2-3 months to be fully operational.

AFFU
Investor082 Investor082 6 minutes ago
Wrong, Gary. A well run biotech (even if they are pre revenue for a decade) will typically finance at increasing valuation as milestones accrue and not do down rounds every year. They continue to fight the bad actors and deliver value to the existing shareholders. That’s how you win the trust of new
NWBO
prototype_101 prototype_101 7 minutes ago
Comprehensive review LWLG known Customer connections

The Customer Funnel slide was updated at the Safe Capital presentation in April 2024 just a few weeks after the OFC 200Gbs World Class demonstrations, this update showed greater than 20 Prospects and greater than 10 Leads, where in
ASM LWLG TWST
sab63090 sab63090 7 minutes ago
Hoskuld,

Thanks, that is different from my search and thanks for the heads up on the additional 60 days to review the NDA Filing plus the 10 months for approval....appreciate you following up to AI misinformation, yet again!
AVXL
AtlasQ AtlasQ 9 minutes ago
Glad to see some of these targets. Billionaires in the making 
RDGL
TenKay TenKay 9 minutes ago
Unfortunately no….but I do have a wicked Blue Steel pose.
HMBL
Prestotic Prestotic 9 minutes ago
Maybe Virexit will get contracts to install Maxclean in Microsofts new data centers in 2025. Imagine, a small cut of 80 billion $. That would be so much better that NO revenue....NO contracts.... yet someone keeps scooping up all the 4's they can get their hands on...
VXIT
HGilS HGilS 9 minutes ago
Hi kayak

I don’t want to start a polemic here this is not the place.

Israel did not send ANY missile on Gaza. Missiles are blind and can hit civilian population.

Bombs were sent after informing civilian population about bombings about to happen.
ELTP
Pittkid Pittkid 9 minutes ago
One of the primary critics on a popular stock forum had consistently targeted the stocks listed below until HUMBL experienced an increase in value in December. Do you notice what all his targeted stocks have in common? A simple review of his posting history provides clear evidence of his interests.
HMBL
ziploc_1 ziploc_1 10 minutes ago
For significant increases in stock price, Amarin needs significant increases in earnings from the U.S...

Patented Lr Et EPA could be a way to produce those earnings.

With the previous success of the Reduce-It study, i.e.as to the safety and efficacy of the EPA drug, Va
AMRN
dstock07734 dstock07734 10 minutes ago
Have you figured out why Merck ran expansion cohort on the neoadjuvant therapy on rGBM patients while the combo trial was undergoing? Any idea why Dr. Liau was not among the coauthors while the rest of her team were listed?

I can see that Merck was very careful and in the data analys
NWBO
fuagf fuagf 11 minutes ago
Yep, bottom line: [...]Related: Musk projects his hard-right influence in Europe
The ever-more powerful Tesla and SpaceX chief is turning his gaze on Europe, where many governments are already grappling with the rise of populism and the far-right.
[...]Musk's political initiatives are
dennisdave dennisdave 11 minutes ago
Saying getting somebody to agree to run what is basically an ATM for them is some sort of huge deal is funny.
NWBO should have initiated an at-the-market (ATM) selling of shares to finance operations years ago as dozens of non revenue biotechs have done.

I still cannot for th
NWBO
doomed doomed 11 minutes ago
We have a bunch of cannabis naive expert on this board…
They seem to know what they are doing…😂
Fools rush in, where wiseman never go…
TLRY
MrMike241 MrMike241 12 minutes ago
Ask about Tri Cascade and the GX500G 5G modem at the Quectel booth. Show them the Quectel PR if necessary. The folks running the booth might not know more than they are there to demonstrate, but it could be interesting 🤔

https://www.quectel.com/customer-stories/iot-5g-modem-rg
SRMX
Jack_Herer Jack_Herer 13 minutes ago
You're not Derek Zoolander?

https://investorshub.advfn.com/uimage/uploads/2021/12/6/bkymec700x420.jpg
HMBL
doomed doomed 13 minutes ago
Tell us what is your favorite Tilray’s bunk strain?
You seem to know them well…😂
TLRY
Chromosome Chromosome 15 minutes ago
Speaking of France does anyone have any information on timing in 2025 other than “sometime in 2025” for reimbursement. I have not been able to find anything in their filings. TIA.
AMRN
Perk_Idaho Perk_Idaho 15 minutes ago
Make that 3.
NWBO

Your Recent History

LSE
0OJ4
Egide
BIT
Q00288
Leonteq Securities
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads